Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorOUAALAYA, El Hassane
dc.contributor.authorFALQUE, L.
dc.contributor.authorDUPIS, J. M.
dc.contributor.authorSABATINI, M.
dc.contributor.authorBERNADY, A.
dc.contributor.authorNGUYEN, L.
dc.contributor.authorOZIER, A.
dc.contributor.authorNOCENT-EJNAINI, C.
dc.contributor.authorLE GUILLOU, F.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOLIMARD, Mathieu
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRAHERISON-SEMJEN, Chantal
dc.date.accessioned2021-03-15T15:41:26Z
dc.date.available2021-03-15T15:41:26Z
dc.date.issued2020-11-22
dc.identifier.issn2590-0412 (Electronic) 2590-0412 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26669
dc.description.abstractEnINTRODUCTION AND OBJECTIVE: Dyspnoea is a major symptom in COPD patients, but the determinants that could be associated with a higher dyspnoea mMRC score in COPD patients remain unclear. Our research aimed to study the determinants of dyspnoea at the threshold of 1, 2, 3 and 4 mMRC. PATIENTS AND METHODS: Diagnosis of COPD was made using spirometry with post-bronchodilator FEV(1)FVC<70%. An online questionnaire has been employed by pulmonologists to recruit COPD patients. The following variables were collected: age, gender, BMI, FEV(1), RV, IC, TLC, FRC, mMRC, frequency of exacerbations and comorbidities. The LASSO was used to select the variables associated with the mMRC dyspnoea scale in a subgroup (who had no missing IC, RV and FRC values) of 421 COPD patients defined by the previously mentioned variables. RESULTS: One thousand nine hundred and sevety-three patients (65.3% males, average age=66±10, 38% current smokers) were included. Dyspnoea was correlated with a low FEV(1) and with the number of exacerbations in the past 12 months. Multivariate analysis showed that the determinants of dyspnoea(mMRC?2) are: FEV(1): OR=3.71[2.86-4.82]; anxiety: OR=2.52[1.82-3.47]; cough: OR=1.94[1.57-2.40]; bronchiectasis: OR=1.84[1.03-3.29]; age: OR=1.80[1.45-2.24]; hyperinflation (RV/TLC): OR=1.68[1.34-2.11]; ischemic cardiopathy: OR=1.63[1.22-2.18]; hypertension: OR=1.52[1.21-1.91]; exacerbations (?2): OR=1.41[1.10-1.81]; women: OR=1.39[1.10-1.74] and overweight: OR=1.33[1.06-1.67]. The subgroup analysis showed that: FEV(1): OR=3.47[1.96-6.12]; exacerbations (?2) OR=2.31[1.33-4.17] and hyperinflation (IC/TLC) OR=0.57[0.35-0.85] were associated with higher dyspnoea (mMRC?2). CONCLUSION: Our results showed that dyspnoea is related to the severity of airflow limitation, gender, exacerbations, comorbidities and hyperinflation.
dc.language.isoENen_US
dc.title.enThe determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohort
dc.title.alternativeRespir Med Resen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.resmer.2020.100803en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33326922en_US
bordeaux.journalRespiratory Medicine and Researchen_US
bordeaux.page100803en_US
bordeaux.volume79en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.teamEPICENE_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03169818
hal.version1
hal.date.transferred2021-03-15T15:41:32Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Respiratory%20Medicine%20and%20Research&amp;rft.date=2020-11-22&amp;rft.volume=79&amp;rft.spage=100803&amp;rft.epage=100803&amp;rft.eissn=2590-0412%20(Electronic)%202590-0412%20(Linking)&amp;rft.issn=2590-0412%20(Electronic)%202590-0412%20(Linking)&amp;rft.au=OUAALAYA,%20El%20Hassane&amp;FALQUE,%20L.&amp;DUPIS,%20J.%20M.&amp;SABATINI,%20M.&amp;BERNADY,%20A.&amp;rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée